Analysis of Reportable Segments
Ecolab Inc. operates in 3 segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences.
Segment Profit Margin
Ecolab Inc., profit margin by reportable segment
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Global Industrial | 16.35% | 18.56% | 15.34% | 14.06% | 14.80% |
| Global Institutional & Specialty | 14.00% | 9.00% | 19.91% | 19.73% | 20.77% |
| Global Healthcare & Life Sciences | 13.46% | 17.46% | — | — | — |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Global Industrial | Global Industrial segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021 not reaching 2019 level. |
| Global Institutional & Specialty | Global Institutional & Specialty segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. | |
| Global Healthcare & Life Sciences | Global Healthcare & Life Sciences segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021. |
Segment Profit Margin: Global Industrial
Ecolab Inc.; Global Industrial; segment profit margin calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income (loss) | 1,031,000) | 1,106,000) | 854,700) | 768,100) | 722,000) |
| Net sales | 6,304,900) | 5,959,900) | 5,569,900) | 5,462,400) | 4,878,500) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 16.35% | 18.56% | 15.34% | 14.06% | 14.80% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 1,031,000 ÷ 6,304,900 = 16.35%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Global Industrial | Global Industrial segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021 not reaching 2019 level. |
Segment Profit Margin: Global Institutional & Specialty
Ecolab Inc.; Global Institutional & Specialty; segment profit margin calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income (loss) | 556,900) | 321,900) | 1,042,200) | 1,026,900) | 985,700) |
| Net sales | 3,978,200) | 3,577,200) | 5,235,500) | 5,204,500) | 4,744,900) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 14.00% | 9.00% | 19.91% | 19.73% | 20.77% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 556,900 ÷ 3,978,200 = 14.00%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Global Institutional & Specialty | Global Institutional & Specialty segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Profit Margin: Global Healthcare & Life Sciences
Ecolab Inc.; Global Healthcare & Life Sciences; segment profit margin calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income (loss) | 160,900) | 207,600) | —) | —) | —) |
| Net sales | 1,195,400) | 1,189,100) | —) | —) | —) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 13.46% | 17.46% | — | — | — |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 160,900 ÷ 1,195,400 = 13.46%
| Segment profitability ratio | Reportable segment | The company |
|---|---|---|
| Segment profit margin | Global Healthcare & Life Sciences | Global Healthcare & Life Sciences segment profit margin ratio improved from 2019 to 2020 but then slightly deteriorated from 2020 to 2021. |
Net sales
Ecolab Inc., net sales by reportable segment
US$ in thousands
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Global Industrial | 6,304,900) | 5,959,900) | 5,569,900) | 5,462,400) | 4,878,500) |
| Global Institutional & Specialty | 3,978,200) | 3,577,200) | 5,235,500) | 5,204,500) | 4,744,900) |
| Global Healthcare & Life Sciences | 1,195,400) | 1,189,100) | —) | —) | —) |
| Global Energy | —) | —) | 3,334,000) | 3,501,800) | 3,199,300) |
| Other | 1,226,900) | 1,093,300) | 907,500) | 877,600) | 823,500) |
| Corporate | 139,400) | 102,400) | —) | —) | —) |
| Subtotal at fixed currency | 12,844,800) | 11,921,900) | 15,046,900) | 15,046,300) | 13,646,200) |
| Effect of foreign currency translation | (111,700) | (131,700) | (140,600) | (378,100) | 192,100) |
| Consolidated reported GAAP | 12,733,100) | 11,790,200) | 14,906,300) | 14,668,200) | 13,838,300) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Operating income (loss)
Ecolab Inc., operating income (loss) by reportable segment
US$ in thousands
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Global Industrial | 1,031,000) | 1,106,000) | 854,700) | 768,100) | 722,000) |
| Global Institutional & Specialty | 556,900) | 321,900) | 1,042,200) | 1,026,900) | 985,700) |
| Global Healthcare & Life Sciences | 160,900) | 207,600) | —) | —) | —) |
| Global Energy | —) | —) | 379,100) | 358,500) | 338,500) |
| Other | 187,300) | 131,500) | 167,300) | 161,300) | 149,300) |
| Corporate | (318,600) | (347,500) | (409,100) | (307,100) | (208,600) |
| Subtotal at fixed currency | 1,617,500) | 1,419,500) | 2,034,200) | 2,007,700) | 1,986,900) |
| Effect of foreign currency translation | (18,900) | (23,800) | (20,400) | (60,700) | 32,900) |
| Consolidated reported GAAP | 1,598,600) | 1,395,700) | 2,013,800) | 1,947,000) | 2,019,800) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).